A New Lebanese Medication Adherence Scale: Validation in Lebanese Hypertensive Adults

Background. A new Lebanese scale measuring medication adherence considered socioeconomic and cultural factors not taken into account by the eight-item Morisky Medication Adherence Scale (MMAS-8). Objectives were to validate the new adherence scale and its prediction of hypertension control, compared...

Full description

Saved in:
Bibliographic Details
Main Authors: R. Bou Serhal, P. Salameh, N. Wakim, C. Issa, B. Kassem, L. Abou Jaoude, N. Saleh
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:International Journal of Hypertension
Online Access:http://dx.doi.org/10.1155/2018/3934296
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background. A new Lebanese scale measuring medication adherence considered socioeconomic and cultural factors not taken into account by the eight-item Morisky Medication Adherence Scale (MMAS-8). Objectives were to validate the new adherence scale and its prediction of hypertension control, compared to MMAS-8, and to assess adherence rates and factors. Methodology. A cross-sectional study, including 405 patients, was performed in outpatient cardiology clinics of three hospitals in Beirut. Blood pressure was measured, a questionnaire filled, and sodium intake estimated by a urine test. Logistic regression defined predictors of hypertension control and adherence. Results. 54.9% had controlled hypertension. 82.4% were adherent by the new scale, which showed good internal consistency, adequate questions (KMO coefficient = 0.743), and four factors. It predicted hypertension control (OR = 1.217; p value = 0.003), unlike MMAS-8, but the scores were correlated (ICC average measure = 0.651; p value < 0.001). Stress and smoking predicted nonadherence. Conclusion. This study elaborated a validated, practical, and useful tool measuring adherence to medications in Lebanese hypertensive patients.
ISSN:2090-0384
2090-0392